We recently reported that IR treatment upregulated the level of pAKT in T2821 and T2851 lung adenocarcinoma cells, which could be blocked by the HSP90 inhibitor ganetespib [28]. The gene discussed is HSP90AA1; the disease is lung adenocarcinoma.